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Isolation and characterization of aromatase inhibitors from Brassaiopsis
glomerulata (Araliaceae)

Marcy J. Balunas
John M. Pezzuto

, Bin Su , Soedarsono Riswan , Harry H.S. Fong , Robert W. Brueggemeier ,
, A. Douglas Kinghorn

Introduction
Brassaiopsis glomerulata is a member of the Araliaceae that
occurs in south and southeast Asia, including the Vietnamese
peninsula (Van Kiem et al., 2003) and in Indonesia. B. glomerulata is
a large shrub or small tree with thorns on the stems, palmate leaves
with five to seven leaflets, pendulous panicles, and flowers in
glomerulous heads (Regel, 1863). This species has several reported
medicinal uses. In Vietnam, the plant is used to treat rheumatism
and back pain (Van Kiem et al., 2003). In India, a group of
indigenous tribes called the Nagas drink a juice extract of B.
glomerulata bark to aid in digestion and to alleviate constipation.

The Nagas also use a paste of the bark of B. glomerulata to treat bone
fractures and sprains (Changkija, 1999). This species is also used
medicinally in China as one of several kinds of "tongcao"
(unblocking herbs used to promote urination and assist in
lactation) (Shen et al., 1998). Owing to its use as a "tongcao", B.
glomerulata was tested using in vivo anti inflammatory, anti
pyretic, and diuretic models (Shen et al., 1998). Moreover, B.
glomerulata is reported to inhibit carrageenan induced swelling of
rat paws (anti inflammatory), and induce an antipyretic effect
using a rat fever model induced by beer yeast or carrageenan, but
no diuretic effect was reported (Shen et al., 1998).
Aromatase is the enzyme responsible for catalyzing the
biosynthesis of estrogens (estrone and estradiol) from androgens
(androstenedione and testosterone) (Johnston and Dowsett, 2003;
Brueggemeier, 2006). Inhibition of aromatase has been shown to
reduce estrogen production throughout the body to nearly
undetectable levels and aromatase inhibitors are being used
clinically to retard the development and progression of hormone
responsive breast cancers [FDA approved aromatase inhibitors
include anastrozole (Arimidex ® ), letrozole (Femara ® ), and exe
mestane (Aromasin ® )]. As part of a research project directed
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toward the study of new naturally occurring chemopreventive
agents from plants (Kinghorn et al., 2004), the leaves of Brassaiopsis
glomerulata (Blume) Regel (Araliaceae), collected in Indonesia,
were found to inhibit the aromatase enzyme. Very limited
phytochemical studies have been performed on plants in the
genus Brassaiopsis, with the only isolates reported to date being
three known triterpenes of the lupane subgroup (Van Kiem et al.,
2003). Due to the strong aromatase activity and the lack of
previous phytochemical research, bioassay guided fractionation of
the leaves of B. glomerulata was initiated to isolate and identify
compounds with potential aromatase inhibitory (AI) activity.
Results and discussion
A hexane soluble extract of the leaves of B. glomerulata
exhibited signiﬁcant aromatase inhibition with both enzyme
based and cell based AI assays [6.9% control activity (PCA) at
20 mg/mL and 7.2 PCA at 20 mg/mL, respectively]. Bioassay guided
fractionation of the hexane extract led to the isolation of six
compounds of the steroid and triterpenoid classes [spinasterone
(1) (Wandji et al., 2002), stigmasterol (2) (Forgo and Kover, 2004),
spinasterol (3) (Kojima et al., 1990), 7b hydroxy 4,22 stigmasta
dien 3 one (4) (Ayyad, 2002), 6b hydroxystigmasta 4 en 3 one
(5) (Kontiza et al., 2006), and oleanolic acid (6) (Seebacher et al.,
2003)] (Fig. 1). The ethyl acetate extract of B. glomerulata was also
found to exhibit moderate aromatase inhibition with the enzyme
based and cell based AI assays (59.3 PCA at 20 mg/mL and 37.0 PCA
at 20 mg/mL, respectively).
Bioassay guided fractionation of the ethyl acetate extract led to
the isolation of seven compounds of the dipeptide, modiﬁed
peptide, fatty acid, monoterpenoid, and benzenoid classes [N
benzoyl L phenylalaninyl N benzoyl L phenylalaninate (7) (Cata
lan et al., 2003), N acetyl L phenylalaninyl N benzoyl L phenyla
laninate (8) (Xiao et al., 2002), N benzoyl L phenylalanine methyl
ester (9) (Li et al., 2000), linoleic acid (10) (Ramsewak et al., 2001),
( ) dihydroactinidiolide (11) (Mori and Khlebnikov, 1993), ( )

dehydrololiolide (12) (Ravi et al., 1982), and 4 hydroxybenzalde
hyde (13) (Levin and Du, 2002)] (Fig. 1).
Compound 9 was found to be a new natural product, not
previously isolated from any organism. This compound was
previously obtained as a synthetic peptide derivative, and was
prepared using Lewis acid cleavage of a resin bond carbamate (Li
et al., 2000). The stereochemistry of 9 at position C 8 was assigned
tentatively as L based on the comparison of the observed [a]D of
+75o with the literature (Li et al., 2000). Following hydrolysis, a
Marfey’s analysis was undertaken to conﬁrm the stereochemistry
at this position. Marfey’s analysis has become one of the standard
methods for the determination of absolute conﬁguration of
compounds containing modiﬁed amino acid residues (Lang
et al., 2006; Mitova et al., 2006). In the region of interest in the
HPLC chromatogram, a peak appeared corresponding to the L phe
Marfey’s derivative. To conﬁrm this assignment, the Marfey’s
derivatives of L phe and D phe were co injected separately with the
Marfey’s derivative of the hydrolysate of 9. The L phe derivative
directly overlapped the peak of the hydrolysate derivative, while
the D phe derivative eluted considerably after the hydrolysate
derivative. The stereochemistry of 9 at position C 8 was therefore
determined to be L.
Marfey’s analysis was also performed to conﬁrm the stereo
chemistry of 7, with positions C 8 and C 80 both being found to
have the L conﬁguration, which was not determined at the time of
its previous isolation (Catalan et al., 2003). Furthermore, the
absolute stereochemistry of 8 at positions C 8 and C 80 was not
assigned previously (Xiao et al., 2002). Using Marfey’s analysis, the
stereochemistry of positions C 8 and C 80 for compound 8 was
determined to be L at both positions.
The fatty acid, linoleic acid (10), was found to be signiﬁcantly
more active than the positive control, aminoglutethimide (AG) in
the enzyme based AI assay (7.4 PCA at 20 mg/mL) (P < 0.0001)
(Fig. 1). However, linoleic acid (10) was inactive in the cell based
assay [147.6 PCA at 100 mM, the interference of fatty acids in the
non cellular, enzyme based radiometric AI assay was previously

Fig. 1. Compounds isolated from Brassaiopsis glomerulata.

031

reported in Balunas et al., 2006]. Upon the isolation of linoleic acid
from the ethyl acetate extract, the hexane extract was reexamined
for the presence of this compound using comparative TLC patterns
and trace amounts were found in the hexane extract also. Since
unsaturated fatty acids can readily undergo lipid oxidation,
forming hydroperoxides in the presence of oxygen (Boyd et al.,
1992; Banni et al., 1996; Lee et al., 2005), it is possible that linoleic
acid in the B. glomerulata extracts may have been oxidized during
the course of bioassay guided fractionation, resulting in decreasing
levels of activity of subsequent fractionation steps.
The monoterpenoid ( ) dehydrololiolide (12), was found to be
active in the cell based AI bioassay (21.8 PCA at 50 mM) (Fig. 2),
with no statistical difference in aromatase inhibition activity
between compound 12 and the positive control, letrozole
(P < 0.0001). The other monoterpenoid isolated from the ethyl
acetate extract, ( ) dihydroactinidiolide (11), was not able to be
tested in either AI assay due to compound volatilization.
Monoterpenoids commonly undergo volatilization and are thus
often used for ﬂavoring or as perfume ingredients. The decreasing
levels of activity of B. glomerulata during the course of bioassay
guided fractionation may be the result of other active and similarly
volatile monoterpenoids. Two chlorinated monoterpenoid pesti
cides, toxaphene and chlordane, have previously been reported to
decrease aromatase activity in a SK BR 3 cell based AI assay,
although the compounds were not direct inhibitors of aromatase
but rather suppressed aromatase expression by antagonizing
estrogen related receptor a 1 (ERRa 1) (Yang and Chen, 1999;
Chen et al., 2001). The difference in the activity of 12 in the
enzyme based AI assay (91.5 PCA at 20 mg/mL) and in the cell
based AI assay (21.8 PCA at 50 mM) may be the result of indirect
modulation of aromatase activity as was found with these
chlorinated monoterpenoid pesticides.
The new natural product, N benzoyl L phenylalanine methyl
ester, 9, was also found to be moderately active in the cell based AI
bioassay (33.3 PCA at 50 mM), although 9 was not active in the
enzyme based AI assay (94.3 PCA at 20 mg/mL). Some structural
similarities exist between the chemical structure of 9 and letrozole,
one of the AIs currently in clinical use, with two benzyl rings
separated by an alkyl linker that contains a nitrogen. However, a
detailed investigation of the structural similarities of 9 as

compared with anastrozole and letrozole was not possible during
the course of the present study.
6b Hydroxystigmasta 4 en 3 one (5) was found to be weakly
active in the cell based AI bioassay. Interestingly, compound 5, as
well as compounds 9 and 12, were not active in the enzyme based
AI assay, perhaps indicating that they are acting through indirect
regulation or modulation of aromatase activity rather than through
direct aromatase inhibition (Yang and Chen, 1999; Chen et al.,
2001; Dı́az Cruz et al., 2005).
Brassaiopsis glomerulata has been reported to have various
ethnobotanical uses, as mentioned earlier. The past history of
medicinal use by human populations of B. glomerulata may be
indicative of being safe when consumed. The strong aromatase
inhibition of the hexane extract of B. glomerulata in both enzyme
and cell based assays, coupled with the possibility of a favorable
safety proﬁle, may point to the potential for use of B. glomerulata
for the chemoprevention of breast cancer. Further investigations of
B. glomerulata are needed, including a recollection and subsequent
bioassay guided compound isolation, as well as further biological
studies on the mechanism of aromatase inhibition and in vivo
testing.
Experimental
General experimental procedures
Enantiomerically pure standards L phenylalaninol (L phe ol), D
phenylalaninol (D phe ol), L phenylalanine (L phe), and D pheny
lalanine (D phe) were purchased from Sigma Aldrich (St. Louis,
MO). Na (2,4 Dinitro 5 ﬂuorophenyl) L alaninamide (L FDAA,
Marfey’s reagent) was purchased from Sigma Aldrich (St. Louis,
MO). HPLC of Marfey’s derivatives was performed using two
Waters 515 pumps and a Waters 2487 dual wavelength detector
(Waters, Milford, MA). A preparative Waters SunFireTM C18 column
(19  150 mm) was used for fractionation, while an analytical
Waters SunFireTM C18 column (4.6 mm  150 mm) was used for
Marfey’s analysis. Solvents were HPLC grade and used without
further puriﬁcation. Radiolabeled [1b 3H]androst 4 ene 3,17
dione, scintillation cocktail 3a70B, and SK BR 3 human breast
cancer cells were obtained as described previously (Brueggemeier
et al., 2005). Radioactivity was counted on an LS6800 liquid
scintillation counter (Beckman, Palo Alto, CA). All other chemicals
and reagents were purchased from Sigma Aldrich (St. Louis, MO).
Plant material
The leaves of Brassaiopsis glomerulata (Blume) Regel were
collected by Dr. Soedarsono Riswan, Herbarium Bogoriense, Bogor,
Indonesia, in 1996 (collection number BK 35). Dried plant material
was stored at ambient temperature at the UIC Pharmacognosy
Field Station in Downers Grove, Illinois until used for the present
study. A voucher specimen (accession number P1750) has been
deposited at the Field Museum of Natural History, Chicago, Illinois.
Extraction and isolation

Fig. 2. Percent control activity (PCA) at 20 mg/mL for compounds 1–13 isolated from
Brassaiopsis glomerulata in the non-cellular, enzyme-based aromatase bioassay and
in SK-BR-3 hormone-independent human breast cancer cells that overexpress
aromatase
(DMSO = dimethyl
sulfoxide,
blank/negative
control;
AG =
aminoglutethimide, positive control in non-cellular assay, 50 mM; LET =
letrozole, positive control in cell-based assay, 10 nM). Each bar represents the
mean and standard error of three replicates, with statistically signiﬁcant differences
indicated in the non-cellular assay by different numbers of stars and in the cellbased assay by different letters (P < 0.0001).

Air dried leaves of B. glomerulata (1.1 kg) were ground and
extracted with methanol overnight (3  3 L). The macerate was
concentrated in vacuo (46.1 g) and partitioned to afford a
petroleum ether extract (11.6 g), an ethyl acetate extract (8.2 g),
and an aqueous extract (13.3 g).
The petroleum ether extract was fractionated using Si gel
vacuum liquid chromatography (Aldrich, Si gel 60, 63 200 mesh,
8.5  18 cm) using 100% petroleum ether, followed by a gradient of
increasing polarity of petroleum ether ethyl acetate, followed, in
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turn, by ethyl acetate methanol. The column was then washed
with 100% methanol. Altogether, 10 pooled fractions (F005 F014)
were collected. Compound 1 (3.6 mg) was obtained as a precipitate
from F006. A white solid precipitated from fraction F007, a mixture
of two related compounds, and was chromatographed using silica
gel (Aldrich, Si gel 60, 230 400 mesh, 4.5  46 cm), beginning with
8:1 hexane ethyl acetate, followed by a gradient of increasing
polarity, and washed with 100% methanol to afford puriﬁed
stigmasterol (2, 2.2 mg) and puriﬁed spinasterol (3, 1.9 mg).
Fractions F008, F009, and F010 were all considered active in the
non cellular assay and were combined based on similar TLC
proﬁles (for a total of 3.1 g). F008 F010 was fractionated using
Diaion HP 20 sorbent (Aldrich, 4.0  21 cm), eluted by 1:1 MeOH
H2O, 3:1 MeOH H2O, 100% MeOH, 3:1 MeOH acetone, 1:1 MeOH
acetone, and 100% acetone. Compound 6 (2.7 mg) was obtained as
a white precipitate from the 100% MeOH fraction. The 3:1 MeOH
acetone fraction (1.9 g) was further fractionated (Aldrich, Si gel 60,
230 400 mesh, 2.5  45 cm), starting with 9:1 hexane acetone
and continuing with increasing polarity until washing with 100%
acetone, followed by 100% methanol. Five pooled fractions were
obtained with the 3:2 hexane acetone fraction (0.09 g) being
further fractionated by preparative reversed phase HPLC (92%
methanol in water, 8 mL/min, monitoring at 238 and 275 nm),
yielding 4 (1.1 mg, tR 36.8 min) and 5 (0.4 mg, tR 50.4 min).
The ethyl acetate extract (8.1 g) was fractionated using Si gel
vacuum liquid chromatography (Aldrich, Si gel 60, 63 200 mesh,
8.5  19 cm), beginning with 100% petroleum ether, followed by a
gradient of petroleum ether ethyl acetate, ethyl acetate metha
nol, and 100% methanol. Altogether 17 pooled fractions (F029
F045) were collected. Compound 7 (19.8 mg) precipitated from
fraction F034. F031 (0.01 g) was subjected to further fractionation
(Aldrich, Si gel 60, 230 400 mesh, 1.0  15 cm) using an isocratic
5:1 hexane ethyl acetate system, yielding pure compound 10
(0.1 mg). Fractions F032 and F033 were combined (0.1 g) and
fractionated by preparative reversed phase HPLC separations (60%
water in acetonitrile, 7 mL/min, monitoring at 220 and 254 nm) to
afford 11 (0.9 mg, tR 11.5 min).
Fraction F034 (0.3 g) was chromatographed using Sephadex LH
20 gel (Aldrich, 2.5  76 cm) in methanol, to afford 12 pooled
fractions (F055 F066). The combination of F057 F058 (0.1 g) was
worked up by preparative reversed phase HPLC separations (7 mL/
min, monitoring at 220 and 254 nm). The solvent conditions for
separation involved a 85:15 water acetonitrile system for 10 min
followed by a 60 min gradient to 1:9 water acetonitrile, to afford
compounds 12 (3.5 mg, tR 29.5 min), 9 (0.8 mg, tR 46.1 min), and 8
(3.7 mg, tR 50.8 min). Fractions F059 and F060 were combined
(0.02 g) and separated using preparative reversed phase HPLC
separations (7 mL/min, monitoring at 220 and 254 nm). The
solvent conditions for separation involved a 85:15 water
acetonitrile system for 15 min followed by a 45 min gradient to
1:9 water acetonitrile, to afford compound 13 (1.9 mg, tR
24.2 min).
Marfey’s analysis
Samples of 7 9 were independently hydrolyzed at 110 8C with
6N HCl for 1 h (Fujii et al., 2002). Hydrolysates were dried and
Marfey’s derivatives were prepared following a published proce
dure (Fujii et al., 2002). The dried hydrolysates of 7 9, as well as the
standards L phe ol, D phe ol, L phe, and D phe, were each dissolved
in 100 mL of water. A 1 M sodium bicarbonate solution was
prepared and 40 mL was added to each sample. A 1% (w/v) solution
of L FDAA in acetone was prepared and 100 mL was added to each
vial. Each vial was then vortexed and incubated at 40 8C for 1 h. To
quench reactions, 40 mL of 1N HCl were added. Each of the Marfey’s

derivatives of the hydrolysates and standards were separately
analyzed by HPLC. All four Marfey’s derivatives of the standards
were then analyzed concurrently. Each Marfey’s derivative of the
hydrolysates was then analyzed concurrently with each Marfey’s
derivative of the standards. The reaction mixtures were analyzed
by HPLC using a 5 min isocratic mobile phase of 30% CH3CN/70%
0.01N aqueous TFA followed by a gradient elution proﬁle to 90%
CH3CN/10% 0.01N aqueous TFA over 60 min at a ﬂow of 1 mL/min,
monitoring at 340 and 256 nm.
Non cellular, enzyme based aromatase bioassay
This assay was performed as described in earlier publications
(Kellis and Vickery, 1987; O’Reilly et al., 1995; Balunas et al., 2006).
Human placental microsomes were obtained from human term
placentas that were processed at 4 8C immediately after delivery
from The Ohio State University Medical Center [OSU Institutional
Review Board (IRB) protocol number 2002H0105, last approved in
December 2006]. Extracts and compounds were originally
screened at 20 mg/mL in DMSO using a non cellular microsomal
radiometric aromatase assay. Samples [extracts or compounds,
DMSO as negative control, or 50 mM () aminoglutethimide (AG) as
positive control] were tested in triplicate. Each reaction mixture
included
sample,
100 nM
[1b 3H]androst 4 ene 3,17 dione
(400,000 450,000 dpm), 0.1 M potassium phosphate buffer (pH
7.0), 5% propylene glycol, and an NADPH regenerating system
(containing 2.85 mM glucose 6 phosphate, 1.8 mM NADP+, and
1.5 units glucose 6 phosphate dehydrogenase). Microsomal aroma
tase (50 mg) was added to initiate the reactions, which were then
incubated in a shaking water bath at 37 8C, and quenched after 15 min
using 2 mL CHCl3. An aliquot of the aqueous layer was then added to
3a70B scintillation cocktail for quantitation of the formation of 3H2O.
Percent control activity (PCA) was determined as previously
described (Kellis and Vickery, 1987; O’Reilly et al., 1995; Balunas
et al., 2006).
Cell based aromatase bioassay
Samples found to be active using the non cellular assay were
further tested at various concentrations in SK BR 3 human breast
cancer cells that overexpress aromatase, using a previously
described method (Natarajan et al., 1994; Richards and Bruegge
meier, 2003; Balunas et al., 2006). Cells were treated in triplicate
with samples or 0.1% DMSO (negative control) or 10 nM letrozole
(positive control). Results are initially determined as picomoles of
3
H2O formed per hour incubation per million live cells (pmol/h/106
cells), with PCA calculated by comparison with the negative
control, DMSO.
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